NYSE:DLB - Dolby Laboratories Stock Price, Price Target & More

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories announced a quarterly dividend on Tuesday, April 24th. Investors of record on Monday, May 7th will be given a dividend of $0.16 per share on Wednesday, May 16th. This represents a $0.64 annualized dividend and a dividend yield of 0.99%. The ex-dividend date of this dividend is Friday, May 4th. View Dolby Laboratories' Dividend History.

Dolby Laboratories announced that its Board of Directors has approved a stock repurchase plan on Sunday, April 9th 2017, which allows the company to repurchase $200,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 3.9% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board of directors believes its shares are undervalued.

Dolby Laboratories, Inc. (NYSE:DLB) issued its quarterly earnings results on Tuesday, April, 24th. The electronics maker reported $0.78 EPS for the quarter, beating the Zacks' consensus estimate of $0.64 by $0.14. The electronics maker had revenue of $301.36 million for the quarter, compared to analyst estimates of $300.37 million. Dolby Laboratories had a net margin of 7.64% and a return on equity of 12.73%. Dolby Laboratories's revenue was up 12.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.63 EPS. View Dolby Laboratories' Earnings History.

Dolby Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Dolby Laboratories.

Dolby Laboratories updated its third quarter earnings guidance on Tuesday, April, 24th. The company provided EPS guidance of $0.78-0.84 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.97. The company issued revenue guidance of $310-320 million, compared to the consensus revenue estimate of $330.43 million.

5 brokers have issued 1-year target prices for Dolby Laboratories' stock. Their forecasts range from $52.00 to $78.00. On average, they anticipate Dolby Laboratories' share price to reach $65.20 in the next twelve months. This suggests a possible upside of 1.3% from the stock's current price. View Analyst Ratings for Dolby Laboratories.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Dolby Laboratories include InterDigital (IDCC), TiVo (TIVO), RPX (RPXC), Acacia Research (ACTG), Finjan (FNJN), Quarterhill (QTRH), Joint (JYNT), Digital Turbine (APPS), Liberty Tax (TAX), ITUS (ITUS), MGT Capital Investments (MGTI), XCel Brands (XELB), Marathon Patent Group (MARA), Research Frontiers (REFR) and ARC Group (ARCK).

Headlines about DLB stock have been trending somewhat positive on Wednesday, Accern Sentiment reports. The research firm scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Dolby Laboratories earned a media sentiment score of 0.11 on Accern's scale. They also gave news headlines about the electronics maker an impact score of 47.50 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Dolby Laboratories' stock is owned by many different of retail and institutional investors. Top institutional investors include DOLBY DAGMAR (41.00%), DOLBY DAGMAR (40.60%), Bank of Montreal Can (0.27%), Baillie Gifford & Co. (0.21%), American Capital Management Inc. (0.11%) and Denali Advisors LLC (0.04%). Company insiders that own Dolby Laboratories stock include Bob Borchers, Dagmar Dolby, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Michael Bergeron, N William Jasper, Jr, Nicholas Donatiello Jr, Nicholas Donatiello, Jr, Peter C Gotcher and Steven E Forshay. View Institutional Ownership Trends for Dolby Laboratories.

DLB stock was sold by a variety of institutional investors in the last quarter, including Baillie Gifford & Co. and Radnor Capital Management LLC. Company insiders that have sold Dolby Laboratories company stock in the last year include Bob Borchers, Dagmar Dolby, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, N William Jasper, Jr, Nicholas Donatiello Jr, Peter C Gotcher and Steven E Forshay. View Insider Buying and Selling for Dolby Laboratories.

DLB stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, American Capital Management Inc., Boston Advisors LLC, Contravisory Investment Management Inc., State of Alaska Department of Revenue and Denali Advisors LLC. View Insider Buying and Selling for Dolby Laboratories.

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of DLB stock can currently be purchased for approximately $64.35.

Dolby Laboratories has a market capitalization of $6.50 billion and generates $1.08 billion in revenue each year. The electronics maker earns $201.80 million in net income (profit) each year or $2.20 on an earnings per share basis. Dolby Laboratories employs 2,122 workers across the globe.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]